Description
Gliclazide (GLIZ) MR 60mg Tablets (30’s)
Gliclazide MR 60mg is a modified-release oral antidiabetic medication belonging to the sulfonylurea class. It is prescribed for managing blood glucose levels in patients with type 2 diabetes mellitus.
Key Features:
-
Stimulates pancreatic beta cells to release insulin, helping reduce blood sugar.
-
Modified-release formulation ensures a steady release, providing prolonged blood glucose control.
-
Once-daily dosing enhances patient compliance.
-
Effective as monotherapy or in combination with other antidiabetic drugs.
-
Helps reduce complications related to poor blood sugar control.
Indications:
-
Management of type 2 diabetes mellitus in adults when diet and exercise alone do not provide adequate glycemic control.
-
Can be used as monotherapy or combined with other agents including metformin or insulin.
Dosage & Administration:
-
Usually taken once daily with breakfast or the first main meal.
-
Dosage individualized based on patient response and risk of hypoglycemia.
-
Regular monitoring of blood glucose is recommended.
Precautions:
-
Not suitable for type 1 diabetes or diabetic ketoacidosis.
-
Caution advised in patients with liver or kidney impairment.
-
Educate patients about hypoglycemia symptoms.
-
Review all medications to avoid potential drug interactions.
Possible Side Effects:
-
Hypoglycemia (low blood sugar)
-
Weight gain
-
Gastrointestinal discomfort such as nausea or indigestion
-
Rare allergic reactions
Storage:
-
Store below 30°C in a dry place.
-
Keep out of reach of children.
Reviews
There are no reviews yet.